MedPath

Two-group, parallel, double-blind study to evaluate the effects of limonite intake on glucose metabolism during 12 weeks.

Not Applicable
Conditions
Healthy person (high fasting blood glucose level, up to 125 mg / dl)
Registration Number
JPRN-UMIN000039470
Lead Sponsor
Mie University, Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) HbA1c value measured during the observation period exceeded 6.5 2) Persons who do not take iron preparations or supplements or drugs intended to take iron (meaning iron 10 mg / day or heme iron more than 100 mg/day) 3) A person who is judged by the doctor to have high blood pressure based on the blood pressure measured during the observation period. (If the measured value exceeds 200 mmHg at the time of visit, the doctor who interviews and judges three times.) 4) Patients who go to the hospital regularly and need to be treated with medicines such as oral medicines (Glucose tolerance and intestinal flora are not affected and transient ones are not excluded. Example: Cold, Transient dermatitis, etc.,Exclude hospital visits due to chronic illness with or without effects) 5) Patients who are judged by the investigator or investigator to be inappropriate as subjects

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glucose metabolism (comparison of changes in fasting blood glucose level from the initial value at 12 weeks)
Secondary Outcome Measures
NameTimeMethod
Glucose metabolism (fasting blood glucose levels other than primary outcomes, HbA1c, insulin), iron (serum ferritin, serum iron, TIBC (iron binding ability)), intestinal flora (intestinal flora, defecation frequency), safety
© Copyright 2025. All Rights Reserved by MedPath